FDA green-lights breast thermography system

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

The FDA has cleared UE LifeSciences NoTouch BreastScan as an adjunctive diagnostic screening tool for the detection of breast cancer.

NoTouch BreastScan is a computerized functional infrared imaging system with a dual-infrared detector design. It does not require manual interpretation of thermal data; instead, it analyzes temperature pixels from various infrared frames to create a report.

The Philadelphia-based developer of breast cancer detection systems plans to offer NoTouch BreastScan services to gynecology, medical oncology and radiology clinics in the U.S. starting in the New York, New Jersey and Pennsylvania regions.